Guerbet Worldwide
Australia
Austria
Belgium
Brazil
Chile
China
Colombia
France
Germany
India
Italy
Japan
Korea
Mexico
Netherlands
Switzerland
South Africa
Spain
Taiwan
United Kingdom
USA
Contact
English
Français
GBT
€19.46
Our Group
Guerbet in a Nutshell
Our Corporate Responsibilities
Our History & Future
Corporate Governance
Careers
My Career Path
Our Job Families
Reasons to Join Us
Stories
Products & Solutions
MRI
Home of MRI Innovations
Dotarem
®
Elucirem™ (Gadopiclenol)
Artirem
®
Injectors, Accessories & Consumables
OptiStar
®
Elite
MRI Accessories
Ready-Box
Consumables for Diagnostic Imaging
Service & Support
OptiProtect™ 3S
CT
Contrast Agents
Xenetix
®
/ ScanBag
®
by Xenetix
®
Optiray
®
Telebrix
®
Gastro
Conray
®
/ Cysto-Conray
®
Micropaque
®
/ Microtrast
®
Injectors, Accessories & Consumables
OptiVantage™ Single-use
OptiVantage™ Multi-use
OptiOne™
Ready-Box
Consumables for Diagnostic Imaging
OptiBolus
®
Service & Support
OptiProtect™ 3S
Cath Lab
Contrast Agents
Xenetix
®
/ ScanBag
®
by Xenetix
®
Optiray
®
Injectors, Accessories & Consumables
Illumena
®
Néo
Ready-Box
Consumables for Diagnostic Imaging
Service & Support
OptiProtect™ 3S
Interventional Radiology
Pharmaceutical Drugs
Lipiodol
®
Ultra Fluid
Medical Devices
Qitexio
®
Women's Health
Pharmaceutical Drugs
Lipiodol
®
Ultra Fluid
Patent Blue V
Urology
Urology
Hydra Vision™ Digital Imaging System
Urology Accessories & Consumables
Investors
Key Figures
Stock Performance
Financial Policy
Presentations, Reports & Regulated information
Agenda
General Meetings
Media
Educational Resources
Patient Resources
Careers
General Meeting of May 24, 2024
Homepage
Investors
General Meetings
2024 General Meeting
Notice of meeting brochure
Universal Registration Document
